| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 上市前/上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 |
| 流动资产： | |||
| 货币资金(元) | 3,799,327.79 | 3,838,486.80 | 31,303,538.71 |
| 应收票据及应收账款(元) | 46,495,629.44 | 61,373,000.31 | 29,896,225.24 |
| 其中：应收账款(元) | 46,495,629.44 | 61,373,000.31 | 29,896,225.24 |
| 预付款项(元) | 65,234,752.95 | 33,297,994.13 | 59,685,821.35 |
| 其他应收款(元) | 284,384.82 | 123,708.30 | 130,747.12 |
| 存货(元) | 34,139,623.18 | 30,922,765.54 | 30,936,371.10 |
| 其他流动资产(元) | - | 1,198,000.35 | 11,801.10 |
| 流动资产合计(元) | 149,953,718.18 | 130,753,955.43 | 151,964,504.62 |
| 非流动资产： | |||
| 长期股权投资(元) | - | 561,040.36 | 574,854.22 |
| 固定资产(元) | 126,605,789.28 | 131,509,075.73 | 139,413,498.53 |
| 在建工程(元) | 28,148,261.29 | 30,798,261.29 | 18,198,261.29 |
| 生产性生物资产(元) | 18,409,364.01 | 18,508,808.92 | 18,495,697.30 |
| 使用权资产(元) | 2,565,579.60 | 2,391,144.63 | 2,518,958.49 |
| 无形资产(元) | 17,262,087.80 | 17,475,056.60 | 17,688,025.40 |
| 非流动资产合计(元) | 192,991,081.98 | 201,243,387.53 | 196,889,295.23 |
| 资产总计(元) | 342,944,800.16 | 331,997,342.96 | 348,853,799.85 |
| 流动负债： | |||
| 短期借款(元) | 20,940,686.60 | 21,309,511.00 | 21,978,335.40 |
| 应付票据及应付账款(元) | 468,564.26 | 725,475.00 | 416,611.60 |
| 其中：应付账款(元) | 468,564.26 | 725,475.00 | 416,611.60 |
| 合同负债(元) | 27,385.54 | 4,275.00 | 193,279.00 |
| 应付职工薪酬(元) | 101,601.50 | 361,403.00 | 209,173.40 |
| 应交税费(元) | 14,335.11 | 135,435.51 | 1,231.51 |
| 应付利息(元) | 3,515,000.00 | 2,220,000.00 | 1,110,000.00 |
| 其他应付款(元) | 788,000.00 | 788,000.00 | 788,000.00 |
| 一年内到期的非流动负债(元) | 15,362,492.78 | 18,630,804.21 | 5,050,000.00 |
| 流动负债合计(元) | 41,218,065.79 | 44,174,903.72 | 29,746,630.91 |
| 非流动负债： | |||
| 长期借款(元) | 33,894,800.00 | 24,067,299.94 | 43,194,800.00 |
| 应付债券(元) | 36,762,964.28 | 36,715,557.14 | 36,668,150.00 |
| 租赁负债(元) | 2,598,268.21 | 2,430,962.03 | 2,381,897.30 |
| 专项应付款(元) | 3,149,000.00 | - | 33,500.00 |
| 递延收益(元) | 91,218,709.06 | 90,430,843.73 | 108,096,454.09 |
| 非流动负债合计(元) | 167,623,741.55 | 153,644,662.84 | 190,374,801.39 |
| 负债合计(元) | 208,841,807.34 | 197,819,566.56 | 220,121,432.30 |
| 所有者权益(或股东权益)： | |||
| 实收资本或股本(元) | 30,680,000.00 | 30,680,000.00 | 30,680,000.00 |
| 资本公积(元) | 17,767,430.55 | 17,767,430.55 | 17,767,430.55 |
| 盈余公积(元) | 6,510,755.59 | 6,510,755.59 | 5,645,406.25 |
| 未分配利润(元) | 77,006,658.59 | 74,793,772.32 | 67,944,753.12 |
| 归属于母公司股东权益合计(元) | 131,964,844.73 | 129,751,958.46 | 122,037,589.92 |
| 少数股东权益(元) | 2,138,148.09 | 4,425,817.94 | 6,694,777.63 |
| 股东权益合计(元) | 134,102,992.82 | 134,177,776.40 | 128,732,367.55 |
| 负债和股东权益合计(元) | 342,944,800.16 | 331,997,342.96 | 348,853,799.85 |
| 公告日期 | 2023-08-21 | 2023-03-31 | 2022-08-10 |
| 审计意见(境内) | 标准无保留意见 | ||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |